Walleye Trading LLC Uni Qure N.V. Call Options Transaction History

Walleye Trading LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$5.63 - $8.27 $25,898 - $38,042	-4,600 Reduced 26.74%	12,600 $85,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $114,070 - $201,110	17,000 Added 8500.0%	17,200 $115,000
Q2 2023 Aug 14, 2023	SELL	$11.12 - $22.2 $289,120 - $577,200	-26,000 Reduced 99.24%	200 $2,000
Q1 2023 May 15, 2023	BUY	$18.7 - $23.07 $489,940 - $604,434	26,200 New	26,200 $527,000
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $146,853 - $182,133	-4,900 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$29.24 - $42.03 $143,276 - $205,947	4,900 New	4,900 $165,000
Q3 2020 Nov 16, 2020	SELL	$35.98 - $47.66 $3,597 - $4,766	-100 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$45.06 - $67.74 $815,586 - $1.23 Million	-18,100 Reduced 99.45%	100 $5,000
Q1 2020 May 15, 2020	BUY	$40.01 - $73.97 $384,096 - $710,112	9,600 Added 111.63%	18,200 $864,000
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $211,641 - $425,334	5,700 Added 196.55%	8,600 $616,000
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $15,744 - $30,720	400 Added 16.0%	2,900 $114,000
Q2 2019 Aug 14, 2019	SELL	$52.76 - $82.19 $221,592 - $345,198	-4,200 Reduced 62.69%	2,500 $195,000
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $183,513 - $458,347	6,700 New	6,700 $400,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.